CJC-1295 + Ipamorelin
In stockOne lyophilized vial supplying CJC-1295 without DAC, a growth hormone-releasing hormone analogue, and ipamorelin, a growth hormone secretagogue. Each component is also listed on its own page.
Supplied as a co-lyophilized vial with a colour-coded cap (Muscle Growth).
Research literature, not dosing or treatment instructions.
- CJC-1295 no DAC: Growth hormone-releasing hormone acts at a pituitary G-protein-coupled receptor that was cloned in 1992; reviews describe its signal transduction and physiology. (PMID 1333056)
- Ipamorelin: Growth hormone secretagogues act at a G-protein-coupled receptor of the pituitary and hypothalamus, cloned in 1996; ghrelin was later identified as its endogenous ligand. (PMID 8688086)
Add the solvent slowly along the vial wall; swirl gently, never shake. Allow to dissolve fully. Six-step guide with photos →
Concentration calculator only. Enter the mass being calculated; blend components are not added automatically. Products are for in-vitro research.
Refer to the product label and supplier documentation for storage conditions. Lot-specific storage and expiry information is not available here.
Each certificate is published with its lot number.
Questions about CJC-1295 + Ipamorelin
Is CJC-1295 + Ipamorelin an approved medicine?
CJC-1295 + Ipamorelin combines research compounds we also list on their own. It is not a medicinal product, and it is supplied for in-vitro laboratory research only, not for human or veterinary use. Regulator records are listed per component on the pages of CJC-1295 no DAC and Ipamorelin.
Which two compounds are in this vial?
CJC-1295 without DAC, a 29-residue amidated analogue of growth hormone-releasing hormone, and ipamorelin, a synthetic pentapeptide growth hormone secretagogue. They are listed separately as single compounds.
Is there published research on CJC-1295 + Ipamorelin as a combination?
No formulation-level literature is listed. Each component's page lists its own studies. The page of each component in the research library lists its own studies.
Is this product for human use?
No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.
Where can I find shipping information?
Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.
For research use only. Not for human or veterinary use.
What is CJC-1295 + Ipamorelin?
A catalog item that supplies CJC-1295 without DAC and ipamorelin together in one vial. Each component keeps its own chemistry, cited studies and regulator records, listed below. We supply CJC-1295 + Ipamorelin as a lyophilized vial for in-vitro laboratory research only.
What does a CJC-1295 + Ipamorelin vial contain?
CJC-1295 + Ipamorelin supplies CJC-1295 no DAC and Ipamorelin together in one vial. The single compounds are listed separately; the amount of each in the vial is shown on the product options.
- CJC-1295 no DAC: gHRH(1-29) analogue, amidated (C152H252N44O42, 3367.9 Da, CAS 863288-34-0).
- Ipamorelin: pentapeptide growth hormone secretagogue (C38H49N9O5, 711.9 Da, CAS 170851-70-4).
What does published research on CJC-1295 + Ipamorelin cover?
CJC-1295 + Ipamorelin combines compounds we also list on their own, so no study covers this exact vial. Each component has its own studies, checked in PubMed on 5 October 2026. One cited study per component follows.
- CJC-1295 no DAC: Growth hormone-releasing hormone acts at a pituitary G-protein-coupled receptor that was cloned in 1992; reviews describe its signal transduction and physiology. (Mayo, Mol Endocrinol, 1992; PMID 1333056)
- Ipamorelin: Growth hormone secretagogues act at a G-protein-coupled receptor of the pituitary and hypothalamus, cloned in 1996; ghrelin was later identified as its endogenous ligand. (Howard et al., Science, 1996; PMID 8688086)
Mechanism, every cited study and the regulator records are on the CJC-1295 + Ipamorelin page of the research library. Papers are listed by what they measured, not as evidence of any use.
How is CJC-1295 + Ipamorelin supplied and stored?
CJC-1295 + Ipamorelin is supplied as a co-lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.
What is the regulatory status of CJC-1295 + Ipamorelin?
CJC-1295 + Ipamorelin combines research compounds we also list on their own. It is not a medicinal product. Regulator records are listed per component.
CJC-1295 no DAC: The EMA medicines database (checked 5 October 2026) lists no centrally authorised medicine naming CJC-1295 no DAC (searched as CJC-1295) as an active substance. National authorisations are not in that dataset.
Ipamorelin: The EMA medicines database (checked 5 October 2026) lists no centrally authorised medicine naming Ipamorelin as an active substance. National authorisations are not in that dataset.
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Which related research pages and compounds are listed?
- CJC-1295 + Ipamorelin: chemistry, literature and regulatory status
- How to read a certificate of analysis
Components in the catalog: